Skip to main content
Canna~Fangled Abstracts

Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors

By October 2, 2023October 12th, 2023No Comments

. 2023 Oct 2.

doi: 10.1007/s12640-023-00671-2.

Online ahead of print.
Hind Ibork 1, Sara El Idrissi 1, Simo Siyanda Zulu 2, Robert Miller 3, Lhoussain Hajji 4, Annabelle Manalo Morgan 5, Khalid Taghzouti 1, Oualid Abboussi 6
Affiliations 

Abstract

Cerebral metabolic abnormalities are common in neurodegenerative diseases. Previous studies have shown that mitochondrial damage alters ATP production and increases reactive oxygen species (ROS) release which may contribute to neurodegeneration. In the present study, we investigated the neuroprotective effects of cannabidiol (CBD), a non-psychoactive component derived from marijuana (Cannabis sativa L.), on astrocytic bioenergetic balance in a primary cell culture model of lipopolysaccharide (LPS)-induced neurotoxicity. Astrocytic metabolic profiling using an extracellular flux analyzer demonstrated that CBD decreases mitochondrial proton leak, increased spare respiratory capacity and coupling efficiency in LPS-stimulated astrocytes. Simultaneously, CBD increased astrocytic glycolytic capacity and glycolysis reserve in a cannabinoid receptor type 1 (CB1)-dependent manner. CBD-restored metabolic changes were correlated with a significant decrease in the pro-inflammatory cytokines tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) concentration and reduction of ROS production in LPS-stimulated astrocytes. These results suggest that CBD may inhibit LPS-induced metabolic impairments and inflammation by enhancing astrocytic metabolic glycolysis versus oxidative phosphorylation through its action on CB1 receptors. The present findings suggest CBD as a potential anti-inflammatory treatment in metabolic pathologies and highlight a possible role for the cannabinoidergic system in the modulation of mitochondrial oxidative stress. CBD enhances mitochondrial bioenergetic profile, attenuates proinflammatory cytokines release, and ROS overproduction of astrocytes stimulated by LPS. These effects are not mediated directly by CB1 receptors, while these receptors seem to have a key role in the anti-inflammatory response of the endocannabinoid system on astrocytes, as their specific inhibition by SR141716A led to increased pro-inflammatory cytokines release and ROS production. The graphical abstract is created with BioRender.com.

Keywords: Cannabidiol, Cannabinoid receptor 1, Metabolism, Mitochondrial bioenergetics, Primary astrocytes

PubMed Disclaimer

References

    1. Acioglu C, Li L, Elkabes S (2021) Contribution of astrocytes to the neuropathology of neurodegenerative diseases. Brain Res 147291
    1. Adams R, Hunt M, Clark J (1940) Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. I J Am Chem Soc 62:196–200 – DOI
    1. Atalay S, Jarocka-Karpowicz I, Skrzydlewska E (2020) Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants 9:21 – DOI
    1. Athanasiou A, Clarke AB, Turner AE, Kumaran NM, Vakilpour S, Smith PA, Bagiokou D, Bradshaw TD et al (2007) Cannabinoid Receptor Agonists are Mitochondrial Inhibitors: a Unified Hypothesis of How Cannabinoids Modulate Mitochondrial Function and Induce Cell Death 364:131–137
    1. Busquets-Garcia A, Bains J, Marsicano GJN (2018) CB1 receptor signaling in the brain: extracting specificity from ubiquity. 43:4–20

LinkOut – more resources

Leave a Reply